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2One reason why Behavioral and
Psychiatric Genetics (BPG) is important:
• Severe mental illnesses devastate many millions of
lives in the US and worldwide
• Major mental disorders, such as schizophrenia and
bipolar illness, have very strong familial risk factors.
3Classical results from Gottesman’s work summarizing many
studies show strong familial/genetic influence on schizophrenia
4Genetics may be best first step
• The serious mental disorders are very difficult to
understand, and over the long run will require
complex and intertwined genetic, proteomic,
neuroscientific, brain imaging, phenotype refinement
via clinical dialogue, and environmental studies.
• But genetic etiology (causes) and/or genomically-
related pathophysiology may give us the best purchase
on these illnesses in the short run.
5Why BPG is also controversial:
Some social risks of behavioral genetics
• Studies in IQ can be misappropriated to further
“benign neglect” social agendas (recall The Bell
Curve debate in the mid-90s, which revisited a
1969 controversy initiated by Arthur Jensen about
IQ and heritability:
• Careless use of BPG results – either of classical
(quantitative) or molecular – might be used to
impugn ethnic groups with socially disfavored
behavioral patterns regarding aggression/
criminality, etc.
6Current and Past State of BPG
• Currently BPG is in a positive and optimistic
mood – maybe too optimistic
• A very short historical overview will help to
evaluate better where the field has recently been,
and where it may be going
• But first we need to refer to a framework to
understand the fourfold structure of the field, and
within which to discuss advances and forecasts
• Keep in mind all the genes or “alleles” (different
forms of the gene) I discuss are “susceptibility
genes” – risk factors related to disorders
7Kendler: 4 paradigms/levels of BPG
(modified from Kendler, January 2005, American Journal of Psychiatry)
8A quick history:1960s and 1970s work
• There were significant early antecedents to BPG, from
Galton, Fisherean statistics, and the psychology of
individual differences.
• But the subject was also misused in the horrific eugenic
sterilizations in the US and in Nazi death camps.
• The subject began as a separate professional discipline in
1960 with the publication of the first textbook in the field,
Fuller and Thompson’s Behavior Genetics.
• There were major substantive and methodological
advances in BPG during the 1970s in BPG, including
Benzer’s fly work, many twin studies, as well as new
multivariate methods by Jinks, Fulker, and Eaves, among
others.
• These were all at Kendler levels 1 and 2.
9A social flashpoint
• One major social flashpoint in behavioral genetics
occurred in 1969 with the publication of Arthur
Jensen’s "How Much Can We Boost I.Q. and
Scholastic Achievement?," Harvard Educational
Review (1969) 39, 1-123
• Many behavioral geneticists have criticized this
work as inferentially flawed, as did Lewontin,
Feldman, and many others throughout the 1970s.
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The 80s and 90s
• BPG had initial “breakthroughs” at the molecular
level in late 1980s in schizophrenia and
depression, but these subsequently turned out to
be errors, and were withdrawn
• BPG began to flourish more generally in the
1990s with gene finding results (at Kendler’s level
3) – but with too high expectations, which were
very frequently accompanied by excessive hype
11
From 1993
Science—ma
ny just read
the headline
of this report
based on a
finding by
Dean
Hamer’s lab
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Also from Science in 1993
   Abnormal behavior associated with a point mutation
in the structural gene for monoamine oxidase A
    [also known as MAOA – this is an enzyme that metabolizes or breaks down
neurotransmitters]
    Brunner H. G. , et al.
   “Genetic and metabolic studies have been done on a large kindred
in which several males are affected by a syndrome of borderline
mental retardation and abnormal behavior. The types of behavior
that occurred include impulsive aggression, arson, attempted rape,
and exhibitionism….”
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Genes and Crime at UMD in 1995
• By NATALIE ANGIER (from NY Times, September 1995)
• “LIKE the late Richard M. Nixon, the notorious University
of Maryland conference on the genetics of criminal
behavior has been deplored, defeated, kicked around,
thrown to the ground, hounded offstage, and still it lurches
back to the ring, fists clenched, eager to fight the fight of
its own design. Three years ago, David Wasserman, a legal
scholar at the University of Maryland and his colleagues
caused a political Pinatubo [a catastrophic volcanic
eruption] when they sought to organize a meeting to
discuss, as they put it, ‘the meaning and significance of
research on genetics and criminal behavior.’”
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And from Nature Genetics in 1996
• Population and familial association between
the D4 dopamine receptor gene and
measures of Novelty Seeking
Benjamin J, Li L, Patterson C, Greenberg
BD, Murphy DL, Hamer DH.
Laboratory of Clinical Science, National
Institute of Mental Health, National Institutes
of Health, Bethesda, Maryland 20892.
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Something amusing from The NY Times…
16
And even
everybody’s
favorite (?)
excuse…
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The crash of the late 90s and early 00s:
  a Y2K that did happen for BPG
• The initial BPG results did not replicate –
that is additional studies did not support the
first one or two reported findings for
homosexuality genes, for aggression genes,
for novelty seeking genes, etc.
• No new useful results in schizophrenia nor
depressions (bipolar or other forms) were
discovered through 2001
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The hand wringing of ‘02
• Typical of the state of BPG in 2001-2002,
though expressed by a most unusual
spokesperson, was Dean Hamer’s
comments in his watershed October 2002
essay in Science
• That essay spoke of the gloom in the field,
but also of possibly emerging promise – IF
the field were to change its paradigm
19
Dean Hamer’s Hula-Hoops
• “The results [in human behavioral and psychiatric genetics] have
been disappointing and inconsistent. Large and well-funded linkage
studies of the major psychiatric disorders including schizophrenia,
alcoholism, Tourette syndrome, and bipolar disorder have come up
empty-handed; not a single new gene has been conclusively
identified. Most candidate gene findings have failed consistent
replication, and even those that have been verified account for only a
small fraction of total variation. Meanwhile, the statisticians who are
supposed to be guiding and evaluating the research are unable to
agree on how to design experiments or to interpret the results; their
advice has proven as faddish (and useful) as the Hula-Hoop. (from
Science, October, 2002)
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Dean Hamer’s diagnosis…
• “What’s the problem? It’s not the basic premise of linkage and
candidate gene analysis; these approaches have identified dozens
of genes involved in inherited diseases. Nor is it the lack of DNA
sequence information; virtually the entire code of the human
genome is now known. The real culprit is the assumption that the
rich complexity of human thought and emotion can be reduced to a
simple, linear relation between individual genes and behaviors.
This oversimplified model [A on the next slide], which underlies
most current research in behavior genetics, ignores the critical
importance of [1] the brain, [2] the environment, and [3] gene
expression networks [B on the next slide]”(my emphases)
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Hamer’s old and new models
22
The 2002 Caspi et al. MAOA study
• One study Hamer referred to as beginning to meet the demands of a
more complex model was related to his point [2] – the environment
•  The Caspi et al. study reported in Science in August 2002  indicates
two different MAOA alleles (one with high and the other low
activity in metabolizing neurotransmitters) have large associations
with conduct disorder, a conviction record, violent behavior, and
antisocial personality disorder.
• But the gene difference shows itself fully ONLY IF the subject
experienced abuse/maltreatment during childhood.
• Caspi et al. use the environment as a lens through which to look for
the effects of gene (allele) differences
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The Science, 2002 Caspi et al MAOA violence study:
Increased MAOA allele activity decreases chances that early
maltreatment leads to a violent personality
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The Caspi et al. method is extendable
and integrates with neuroscience
• A methodologically similar 2003 study from the
Caspi group on two serotonin transporter alleles
(5-HTT) and depression showed similar gene-
environment interaction (GxE) effects dependent
on stressful life events
• This study was motivated in part by neuroscience
finding: knockout mice, stressed primates, and the
Hariri et al. 2002 amygdala study (which I’ll
mention later), and shows how neuroscience and
BPG can be integrating and mutually
“bootstrapping” (Caspi and Moffitt, 2006, in
press)
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The 2003 Caspi, Moffitt et al. GxE
depression study (Science, 2003)
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And has been extended again…
• Yet another  methodologically similar 200
study from the Caspi group on two COMT
alleles showed an increased risk for
psychosis (schizophrenia) of one allele
• But only IF there was significant cannabis
use during a vulnerable period in the
teenage years
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A start, but maybe not enough?
• Hamer indicated that this 2002 MAOA study is a
significant advance (similar for 2003 study)
• And the Caspi 2002 study on aggression has been
replicated several timesand failed once (meta-
analysis is in press) so it’s likely this is a real
MAOA effect)
• But these studies are still wedded to a single gene
approach (MAOA or 5-HTT).
• Is there a better way – to go beyond just single
genes, and also involve the brain, as Hamer
recommended?
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Involving the brain -- endophenotypes
• Increasingly behavioral and psychiatric geneticists are using
neuroscience and coupling it with genomics, as already
mentioned
• One approach uses “endophenotypes” – gene effects that are
intermediate between gene action and the final disorder such as
schizophrenia. NIMH has funded a large 7 centered grant to
examine endophenotypes in schizophrenia
• They are looking at memory changes and disturbances in eye
tracking that seem to be associated with early schizophrenia, as
well as at neuroimaging patterns – to hopefully get a clearer
signal of gene action.
• Other studies, by Hariri and Weinberger, looked at neuroimaging
amygdala responses related to anxiety and depression for a signal
10x stronger than subjective information  for the (5-HTT) gene.
29
Another way of involving the brain and
many genes – using microarrays
• Microarrays are gene chips – a small glass slide (less than an
inch square) on which many thousands of gene detectors (small
stretches of complementary DNA) are sequentially arranged
• Cells can be obtained by autopsy from disordered brains and
from normal brains (used as controls)
• Many alleles can be tested for simultaneously, and also the
mRNAs in the cell contents -- reflective of which genes are
turned on or expressed -- can be smeared over the gene chips,
and the different expression profiles compared.
• Caveat: many false positives without appropriate corrections for
multiple testing and the very low prior probabilities.
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Implications of the new
complexity
• Gene chip results are underscoring Hamer’s points noted
earlier that any simple genedisorder models are likely to
fail
• Results from simpler model systems like yeast, the worm (C.
elegans), and the fruit fly by KFS and Kendler and
Greensapn show that the neuroscience of behavior involves
very complicated ways that genes act to build and maintain
neurocircuits; many genes act together
• And environment counts! In yeast – a one celled organism –
about 4000 of its 6000 genes are turned on and off by
environmental signals like temperature and acidity.
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Some predictions for the near-
term future of BPG
• Fairly steady progress will occur, but there will be false
starts. We may need protein chips before the results we
get from gene chips clarify, and protein chips are much
harder to make than gene chips, and probably involve
monitoring > 200,000 proteins.
• The steady progress will, however, be slow – there will
be many sets of genes with small effects that will
probably interact to produce disorders. Sorting out all
the genetic heterogeneity will take many studies.
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More predictions…
• The mental disorders will themselves turn out to be a
mix of disorders that need further clarification and
resorting; the disorders will be somewhat reclassified
as we learn more at levels 3 and 4 of BPG (as we
already have in Alzheimer’s Disease(s))
• Reclassification and clarification will involve many
levels of simultaneous study, not just genomics and
proteomics. Neuroimaging studies as well as human
subjective reports from patients or their clinical
records will be needed – as this process goes on. The
methods will have to be integrative and multi-level,
not only simply reductionistic.
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Some troubling implications on the horizon
• Further discovery of  genes that make us different
and can be screened for, may stigmatize some
individuals behaviorally – recall the MAOA findings
of Brunner (1993) and also Caspi et al. (2002)
• It is also possible we may find correlations with
ethnicity of both harmful and protective genes,
currently emerging in pharmacogenomics, which
could lead to new forms of stereotyping and
discrimination.
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Troubling implications…
• Though I have not discussed it today, there is a
molecular genetics IQ program run in the UK by Robert
Plomin, which has published  some weak results for
genes of small effects on IQ. I have discussed this IQ
research program elsewhere In Wrestling with Behaioral
Genetics, Parens et al (eds.)….
• If successful and cognitive capacity genes for IQ and
memory are identified, soon after we will see the pursuit
of “enhancement” therapies. These will be new “smart
drugs,” or as Fortune magazine labeled them, “Viagra
for the mind”
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Conclusions
• Understanding and utilizing these advances will
also require greater appreciation of these subtle
complexities by policy makers as well as the
public, as patients and consumers
• Policy makers will have to proceed both
knowledgeably and cautiously to avoid
enhancement stampedes, as well as to protect
against individual and group discrimination.
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